Expression of EGFR in breast cancer and its correlation to molecular subtyping and hormone receptor status
10.3760/cma.j.issn.1674-6090.2018.05.002
- VernacularTitle:表皮生长因子受体1蛋白表达与乳腺癌分子分型及激素受体状态的关系
- Author:
Chaoqun WANG
1
;
Yan WANG
;
Bifei HUANG
;
Zhenming SU
;
Yongming ZHAO
;
Qian WANG
;
Guinv HU
;
Huajun LU
Author Information
1. 温州医科大学附属东阳医院病理科
- Keywords:
EGFR;
Breast cancer;
Immunohistochemistry;
Molecular classification
- From:
Chinese Journal of Endocrine Surgery
2018;12(5):358-361
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the expression of epidermal growth factor receptor 1 (EGFR) protein in breast cancer and its correlation to molecular subtyping and hormone receptor status.Methods 467 cases of breast cancer were included.According to ER,PR,HER2,and Ki-67 status,the cases were categorized into 4 molecular subtypes,including 185 cases of luminal A,109 cases of luminal B,76 cases of HER2-enriched,and 70 cases of triple-negative breast cancer (TNBC).According to ER and PR status,the cases were divided into 4 subtypes,including 240 cases of ER+/PR+,50 cases of ER+/PR-,4 cases of ER-/PR+,and 173 cases of ER-/PR-.Results EGFR protein expression rates in Luminal A,Luminal B,HER2-enriched and TNBC were 16.8%(31/185),54.1%(59/109),97.4%(74/76),78.6%(55/70),respectively.The EGFR expression in HER2-enriched was significantly higher than those in TNBC,Luminal B and Luminal A(P<0.01),and EGFR expression in TNBC was significantly higher than those in Luminal B and Luminal A (P<0.01),furthermore,EGFR expression in Luminal B was significantly higher than that in Luminal A (P<0.01).EGFR protein expression rates in ER+/PR+ subtype,ER+/PR-subtype,ER-/PR+ subtype and ER-/PR-subtype were 25.4% (61/240),52.0% (26/50),75.0% (3/4),88.4%(153/173),respectively.The EGFR expression in ER-/PR-subtype was significantly higher than in ER+/PR+ subtype and ER+/PR-subtype (P<0.01),and EGFR expression in ER+/PR-subtype was significantly higher than that in ER+/PR+ subtype (P<0.01).EGFR protein expression rate was higher in ER-/PR-subtype than in ER-/PR+ subtype,and EGFR protein expression rate was higher in ER-/PR+ subtype than that in ER+/PR+ subtype and ER+/PR-subtype,but all of the difference were not statistically significant (P>0.05).Conclusion EGFR protein expression is closely related to breast cancer molecular subtyping and negative hormone receptor expression,which is a potential biomarker of anti-breast cancer therapy.